pathology_id stringlengths 19 19 | country stringclasses 7
values | year int64 2.02k 2.03k | facility_type stringclasses 3
values | cancer_type stringclasses 10
values | icd_o_morphology_code stringclasses 9
values | morphology_description stringclasses 9
values | grade stringclasses 4
values | lymphovascular_invasion stringclasses 3
values | perineural_invasion stringclasses 3
values | margin_status stringclasses 4
values | ihc_er stringclasses 3
values | ihc_pr stringclasses 3
values | ihc_her2 stringclasses 4
values | ihc_ki67_index stringclasses 825
values | ihc_p53 stringclasses 3
values | molecular_subtype stringclasses 4
values | specimen_type stringclasses 4
values | diagnosis_confirmed stringclasses 3
values | turnaround_time_days int64 3 27 | scenario stringclasses 1
value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PATH-TAN-2018-00001 | Tanzania | 2,018 | District | Breast | 8070/3 | Squamous cell carcinoma | Well differentiated | Present | Not documented | Positive | Positive | Negative | Not done | Not done | Negative | null | Fine needle aspirate | Yes | 17 | moderate_burden |
PATH-SOU-2020-00002 | South Africa | 2,020 | Regional | Cervix | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Negative | Negative | 12.0 | Positive | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-UGA-2024-00003 | Uganda | 2,024 | Regional | Breast | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Present | Negative | Not done | Negative | Negative | 61.0 | Negative | Triple negative | Excisional biopsy | Yes | 21 | moderate_burden |
PATH-GHA-2023-00004 | Ghana | 2,023 | District | Thyroid | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Not documented | Close | Positive | Not done | Not done | 27.6 | Negative | null | Core needle biopsy | Yes | 12 | moderate_burden |
PATH-SOU-2021-00005 | South Africa | 2,021 | Regional | Bladder | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Not done | Negative | Negative | Not done | Not done | null | Fine needle aspirate | Yes | 22 | moderate_burden |
PATH-UGA-2020-00006 | Uganda | 2,020 | National referral | Breast | 8260/3 | Papillary carcinoma | Poorly differentiated | Present | Absent | Positive | Positive | Positive | Negative | 45.7 | Negative | Triple negative | Resection | Yes | 13 | moderate_burden |
PATH-SOU-2025-00007 | South Africa | 2,025 | Regional | Bladder | 8140/3 | Adenocarcinoma | Well differentiated | Present | Present | Negative | Negative | Negative | Negative | 71.7 | Positive | null | Core needle biopsy | Yes | 25 | moderate_burden |
PATH-UGA-2020-00008 | Uganda | 2,020 | Regional | Cervix | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Not documented | Close | Positive | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-TAN-2021-00009 | Tanzania | 2,021 | National referral | Bladder | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Present | Negative | Not done | Positive | Negative | 28.6 | Positive | null | Core needle biopsy | Yes | 27 | moderate_burden |
PATH-NIG-2025-00010 | Nigeria | 2,025 | District | Lung | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Absent | Negative | Negative | Negative | Negative | 66.3 | Positive | null | Core needle biopsy | No - inconclusive | 4 | moderate_burden |
PATH-TAN-2019-00011 | Tanzania | 2,019 | Regional | Cervix | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Close | Positive | Positive | Negative | Not done | Positive | null | Resection | No - inconclusive | 3 | moderate_burden |
PATH-KEN-2018-00012 | Kenya | 2,018 | Regional | Breast | 8510/3 | Medullary carcinoma | Moderately differentiated | Absent | Not documented | Close | Negative | Positive | Not done | Not done | Positive | Luminal A | Excisional biopsy | Yes | 7 | moderate_burden |
PATH-TAN-2018-00013 | Tanzania | 2,018 | District | Stomach | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Positive | Negative | Not done | Negative | null | Fine needle aspirate | Yes | 24 | moderate_burden |
PATH-KEN-2020-00014 | Kenya | 2,020 | Regional | Breast | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Absent | Positive | Positive | Positive | Equivocal | 64.3 | Positive | null | Resection | Yes | 12 | moderate_burden |
PATH-SOU-2022-00015 | South Africa | 2,022 | Regional | Lung | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Close | Positive | Negative | Negative | 88.6 | Positive | null | Core needle biopsy | No - inconclusive | 18 | moderate_burden |
PATH-ETH-2025-00016 | Ethiopia | 2,025 | District | Breast | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Not documented | Negative | Positive | Positive | Negative | 15.6 | Positive | Triple negative | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-TAN-2019-00017 | Tanzania | 2,019 | National referral | Liver | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Close | Positive | Not done | Negative | 48.9 | Positive | null | Excisional biopsy | Yes | 6 | moderate_burden |
PATH-SOU-2021-00018 | South Africa | 2,021 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Close | Negative | Positive | Negative | 14.0 | Positive | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-SOU-2020-00019 | South Africa | 2,020 | National referral | Breast | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 28.8 | Negative | Luminal A | Excisional biopsy | Yes | 17 | moderate_burden |
PATH-TAN-2024-00020 | Tanzania | 2,024 | District | Liver | 8510/3 | Medullary carcinoma | Well differentiated | Not documented | Not documented | Negative | Positive | Positive | Negative | Not done | Negative | null | Resection | Yes | 17 | moderate_burden |
PATH-UGA-2022-00021 | Uganda | 2,022 | Regional | Cervix | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 78.0 | Negative | null | Resection | Yes | 24 | moderate_burden |
PATH-KEN-2020-00022 | Kenya | 2,020 | Regional | Ovary | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Not documented | Close | Negative | Positive | Positive | 81.6 | Negative | null | Resection | Yes | 26 | moderate_burden |
PATH-UGA-2025-00023 | Uganda | 2,025 | District | Liver | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Negative | Not done | Negative | null | Resection | Yes | 14 | moderate_burden |
PATH-UGA-2020-00024 | Uganda | 2,020 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Not documented | Positive | Positive | Negative | Negative | Not done | Negative | null | Core needle biopsy | Yes | 13 | moderate_burden |
PATH-NIG-2021-00025 | Nigeria | 2,021 | District | Breast | 8260/3 | Papillary carcinoma | Poorly differentiated | Absent | Present | Positive | Positive | Not done | Negative | Not done | Negative | HER2+ | Core needle biopsy | Yes | 26 | moderate_burden |
PATH-SOU-2025-00026 | South Africa | 2,025 | Regional | Cervix | 8510/3 | Medullary carcinoma | Poorly differentiated | Present | Absent | Negative | Negative | Positive | Not done | 40.1 | Positive | null | Fine needle aspirate | Yes | 18 | moderate_burden |
PATH-UGA-2019-00027 | Uganda | 2,019 | Regional | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Positive | Negative | 27.8 | Negative | null | Fine needle aspirate | Yes | 17 | moderate_burden |
PATH-ETH-2025-00028 | Ethiopia | 2,025 | Regional | Colorectal | 8500/3 | Ductal carcinoma | Poorly differentiated | Not documented | Not documented | Positive | Not done | Positive | Negative | 21.8 | Negative | null | Excisional biopsy | No - inconclusive | 26 | moderate_burden |
PATH-NIG-2023-00029 | Nigeria | 2,023 | District | Lung | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Not documented | Positive | Positive | Negative | Negative | 18.9 | Not done | null | Resection | Yes | 13 | moderate_burden |
PATH-KEN-2020-00030 | Kenya | 2,020 | District | Cervix | 8510/3 | Medullary carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Negative | Not done | 50.4 | Positive | null | Excisional biopsy | Yes | 16 | moderate_burden |
PATH-KEN-2020-00031 | Kenya | 2,020 | District | Bladder | 8260/3 | Papillary carcinoma | Undifferentiated | Not documented | Absent | Negative | Negative | Positive | Not done | 9.4 | Positive | null | Fine needle aspirate | Yes | 15 | moderate_burden |
PATH-SOU-2019-00032 | South Africa | 2,019 | District | Prostate | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Present | Not applicable | Not done | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 7 | moderate_burden |
PATH-SOU-2023-00033 | South Africa | 2,023 | District | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Present | Negative | Positive | Positive | Negative | 54.6 | Not done | null | Excisional biopsy | No - inconclusive | 6 | moderate_burden |
PATH-GHA-2024-00034 | Ghana | 2,024 | District | Colorectal | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Not done | Negative | Negative | 25.3 | Not done | null | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-ETH-2025-00035 | Ethiopia | 2,025 | National referral | Lung | 8500/3 | Ductal carcinoma | Well differentiated | Present | Present | Negative | Negative | Positive | Negative | 69.7 | Positive | null | Resection | Yes | 13 | moderate_burden |
PATH-NIG-2022-00036 | Nigeria | 2,022 | District | Ovary | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Close | Positive | Negative | Equivocal | Not done | Positive | null | Resection | Yes | 3 | moderate_burden |
PATH-ETH-2021-00037 | Ethiopia | 2,021 | Regional | Colorectal | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Positive | Negative | 63.9 | Not done | null | Resection | Yes | 27 | moderate_burden |
PATH-ETH-2018-00038 | Ethiopia | 2,018 | Regional | Ovary | 8500/3 | Ductal carcinoma | Poorly differentiated | Not documented | Present | Not applicable | Positive | Positive | Negative | 49.4 | Positive | null | Resection | Yes | 11 | moderate_burden |
PATH-NIG-2024-00039 | Nigeria | 2,024 | District | Thyroid | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Positive | Negative | 19.5 | Not done | null | Resection | Yes | 18 | moderate_burden |
PATH-ETH-2021-00040 | Ethiopia | 2,021 | District | Breast | 8310/3 | Clear cell carcinoma | Moderately differentiated | Absent | Present | Positive | Positive | Positive | Negative | Not done | Negative | Luminal A | Excisional biopsy | Yes | 16 | moderate_burden |
PATH-TAN-2023-00041 | Tanzania | 2,023 | Regional | Bladder | 8260/3 | Papillary carcinoma | Undifferentiated | Absent | Not documented | Negative | Positive | Negative | Negative | 86.3 | Negative | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-TAN-2025-00042 | Tanzania | 2,025 | District | Stomach | 8070/3 | Squamous cell carcinoma | Undifferentiated | Present | Absent | Negative | Negative | Not done | Negative | 34.0 | Negative | null | Core needle biopsy | Yes | 5 | moderate_burden |
PATH-KEN-2020-00043 | Kenya | 2,020 | Regional | Lung | 8310/3 | Clear cell carcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Positive | Negative | Not done | Negative | null | Resection | Yes | 3 | moderate_burden |
PATH-NIG-2021-00044 | Nigeria | 2,021 | District | Cervix | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Positive | Positive | Positive | Negative | Not done | Negative | null | Resection | Yes | 22 | moderate_burden |
PATH-TAN-2018-00045 | Tanzania | 2,018 | District | Breast | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Negative | Negative | Not done | Negative | Not done | Not done | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-SOU-2018-00046 | South Africa | 2,018 | District | Colorectal | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Absent | Close | Not done | Negative | Equivocal | Not done | Negative | null | Resection | Yes | 6 | moderate_burden |
PATH-ETH-2021-00047 | Ethiopia | 2,021 | District | Breast | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Present | Negative | Positive | Negative | Positive | 50.6 | Negative | HER2+ | Resection | Yes | 12 | moderate_burden |
PATH-TAN-2020-00048 | Tanzania | 2,020 | National referral | Lung | 8890/3 | Leiomyosarcoma | Moderately differentiated | Present | Present | Close | Negative | Negative | Negative | 55.0 | Negative | null | Excisional biopsy | Yes | 11 | moderate_burden |
PATH-KEN-2024-00049 | Kenya | 2,024 | District | Cervix | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Present | Not applicable | Positive | Not done | Negative | 24.4 | Positive | null | Fine needle aspirate | Yes | 19 | moderate_burden |
PATH-KEN-2023-00050 | Kenya | 2,023 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Undifferentiated | Not documented | Absent | Not applicable | Negative | Positive | Negative | 75.0 | Not done | null | Fine needle aspirate | Yes | 27 | moderate_burden |
PATH-UGA-2022-00051 | Uganda | 2,022 | District | Colorectal | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Close | Positive | Negative | Negative | Not done | Positive | null | Core needle biopsy | Yes | 25 | moderate_burden |
PATH-ETH-2020-00052 | Ethiopia | 2,020 | National referral | Colorectal | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Present | Negative | Positive | Not done | Negative | 14.6 | Not done | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-TAN-2018-00053 | Tanzania | 2,018 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Positive | Positive | Negative | Negative | 36.2 | Positive | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-TAN-2023-00054 | Tanzania | 2,023 | National referral | Prostate | 8510/3 | Medullary carcinoma | Moderately differentiated | Present | Not documented | Positive | Positive | Positive | Negative | Not done | Positive | null | Excisional biopsy | Yes | 8 | moderate_burden |
PATH-UGA-2025-00055 | Uganda | 2,025 | National referral | Stomach | 8260/3 | Papillary carcinoma | Moderately differentiated | Not documented | Not documented | Negative | Positive | Positive | Negative | 26.8 | Negative | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-GHA-2023-00056 | Ghana | 2,023 | Regional | Breast | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Present | Close | Positive | Positive | Positive | Not done | Positive | null | Resection | Yes | 12 | moderate_burden |
PATH-KEN-2021-00057 | Kenya | 2,021 | Regional | Stomach | 8260/3 | Papillary carcinoma | Undifferentiated | Absent | Absent | Positive | Positive | Negative | Not done | Not done | Negative | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-ETH-2021-00058 | Ethiopia | 2,021 | District | Thyroid | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Negative | Negative | Not done | Positive | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-NIG-2024-00059 | Nigeria | 2,024 | District | Lung | 8510/3 | Medullary carcinoma | Poorly differentiated | Present | Absent | Positive | Positive | Positive | Negative | 79.1 | Positive | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-ETH-2021-00060 | Ethiopia | 2,021 | Regional | Colorectal | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Present | Negative | Negative | Not done | Negative | 65.2 | Positive | null | Resection | Yes | 18 | moderate_burden |
PATH-ETH-2018-00061 | Ethiopia | 2,018 | Regional | Breast | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Not documented | Positive | Positive | Negative | Positive | 78.3 | Not done | Luminal A | Resection | Yes | 24 | moderate_burden |
PATH-TAN-2020-00062 | Tanzania | 2,020 | District | Cervix | 8310/3 | Clear cell carcinoma | Moderately differentiated | Absent | Not documented | Close | Positive | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 5 | moderate_burden |
PATH-NIG-2023-00063 | Nigeria | 2,023 | Regional | Lung | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Present | Negative | Negative | Positive | Negative | 53.5 | Positive | null | Excisional biopsy | Yes | 24 | moderate_burden |
PATH-ETH-2020-00064 | Ethiopia | 2,020 | National referral | Prostate | 8720/3 | Melanoma | Moderately differentiated | Present | Not documented | Negative | Positive | Not done | Negative | Not done | Negative | null | Fine needle aspirate | Yes | 10 | moderate_burden |
PATH-ETH-2021-00065 | Ethiopia | 2,021 | Regional | Bladder | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Close | Positive | Positive | Negative | Not done | Negative | null | Resection | Yes | 23 | moderate_burden |
PATH-KEN-2020-00066 | Kenya | 2,020 | Regional | Bladder | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Positive | Negative | 11.4 | Negative | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-GHA-2024-00067 | Ghana | 2,024 | District | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Not applicable | Negative | Negative | Negative | Not done | Positive | null | Core needle biopsy | No - suboptimal | 22 | moderate_burden |
PATH-GHA-2018-00068 | Ghana | 2,018 | District | Prostate | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Not documented | Close | Negative | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-UGA-2020-00069 | Uganda | 2,020 | District | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Positive | Not done | Not done | null | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-TAN-2023-00070 | Tanzania | 2,023 | Regional | Prostate | 8430/3 | Mucoepidermoid carcinoma | Undifferentiated | Absent | Absent | Negative | Negative | Negative | Not done | 66.5 | Not done | null | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-ETH-2021-00071 | Ethiopia | 2,021 | National referral | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Not documented | Negative | Negative | Positive | Negative | 7.4 | Negative | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-KEN-2024-00072 | Kenya | 2,024 | Regional | Colorectal | 8260/3 | Papillary carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 75.9 | Negative | null | Resection | No - inconclusive | 7 | moderate_burden |
PATH-SOU-2021-00073 | South Africa | 2,021 | National referral | Colorectal | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Negative | Positive | 77.1 | Positive | null | Resection | No - inconclusive | 3 | moderate_burden |
PATH-SOU-2021-00074 | South Africa | 2,021 | National referral | Cervix | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Present | Close | Positive | Negative | Not done | Not done | Positive | null | Resection | Yes | 17 | moderate_burden |
PATH-GHA-2024-00075 | Ghana | 2,024 | District | Ovary | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Negative | Negative | 59.0 | Positive | null | Core needle biopsy | Yes | 8 | moderate_burden |
PATH-TAN-2021-00076 | Tanzania | 2,021 | National referral | Colorectal | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Not documented | Positive | Positive | Negative | Negative | 68.6 | Not done | null | Resection | Yes | 24 | moderate_burden |
PATH-NIG-2020-00077 | Nigeria | 2,020 | District | Cervix | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Absent | Negative | Positive | Negative | Negative | 55.7 | Positive | null | Fine needle aspirate | Yes | 19 | moderate_burden |
PATH-TAN-2023-00078 | Tanzania | 2,023 | Regional | Prostate | 8500/3 | Ductal carcinoma | Moderately differentiated | Not documented | Not documented | Negative | Not done | Negative | Positive | 31.8 | Not done | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-SOU-2024-00079 | South Africa | 2,024 | District | Liver | 8720/3 | Melanoma | Moderately differentiated | Absent | Absent | Negative | Positive | Positive | Positive | Not done | Negative | null | Resection | No - suboptimal | 21 | moderate_burden |
PATH-SOU-2022-00080 | South Africa | 2,022 | National referral | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Not applicable | Negative | Negative | Negative | 22.3 | Positive | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-UGA-2020-00081 | Uganda | 2,020 | National referral | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Not applicable | Negative | Positive | Negative | Not done | Positive | null | Fine needle aspirate | Yes | 14 | moderate_burden |
PATH-UGA-2022-00082 | Uganda | 2,022 | Regional | Lung | 8500/3 | Ductal carcinoma | Well differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 13.5 | Negative | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-UGA-2025-00083 | Uganda | 2,025 | Regional | Ovary | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Negative | Positive | Not done | Negative | null | Resection | Yes | 6 | moderate_burden |
PATH-TAN-2018-00084 | Tanzania | 2,018 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Not documented | Positive | Positive | Negative | Positive | 17.3 | Negative | null | Resection | No - inconclusive | 12 | moderate_burden |
PATH-NIG-2021-00085 | Nigeria | 2,021 | National referral | Breast | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Negative | 28.5 | Negative | Triple negative | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-UGA-2021-00086 | Uganda | 2,021 | District | Thyroid | 8070/3 | Squamous cell carcinoma | Well differentiated | Present | Absent | Negative | Negative | Positive | Negative | Not done | Positive | null | Fine needle aspirate | No - suboptimal | 26 | moderate_burden |
PATH-ETH-2018-00087 | Ethiopia | 2,018 | National referral | Colorectal | 8510/3 | Medullary carcinoma | Well differentiated | Present | Present | Negative | Positive | Negative | Negative | 41.7 | Positive | null | Core needle biopsy | No - suboptimal | 3 | moderate_burden |
PATH-GHA-2025-00088 | Ghana | 2,025 | District | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Not done | Negative | 87.7 | Negative | null | Core needle biopsy | Yes | 14 | moderate_burden |
PATH-TAN-2018-00089 | Tanzania | 2,018 | National referral | Cervix | 8260/3 | Papillary carcinoma | Undifferentiated | Present | Not documented | Not applicable | Negative | Negative | Positive | 46.3 | Positive | null | Core needle biopsy | Yes | 20 | moderate_burden |
PATH-KEN-2025-00090 | Kenya | 2,025 | National referral | Liver | 8140/3 | Adenocarcinoma | Well differentiated | Not documented | Absent | Negative | Not done | Positive | Negative | 13.3 | Positive | null | Excisional biopsy | Yes | 6 | moderate_burden |
PATH-KEN-2025-00091 | Kenya | 2,025 | District | Prostate | 8260/3 | Papillary carcinoma | Poorly differentiated | Absent | Absent | Not applicable | Positive | Negative | Negative | Not done | Positive | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-KEN-2018-00092 | Kenya | 2,018 | National referral | Bladder | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Positive | Negative | 45.1 | Negative | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-UGA-2023-00093 | Uganda | 2,023 | Regional | Thyroid | 8070/3 | Squamous cell carcinoma | Well differentiated | Absent | Not documented | Positive | Negative | Positive | Negative | 69.3 | Positive | null | Excisional biopsy | Yes | 14 | moderate_burden |
PATH-SOU-2018-00094 | South Africa | 2,018 | Regional | Prostate | 8070/3 | Squamous cell carcinoma | Undifferentiated | Not documented | Absent | Negative | Positive | Positive | Negative | 68.2 | Positive | null | Core needle biopsy | No - inconclusive | 10 | moderate_burden |
PATH-KEN-2020-00095 | Kenya | 2,020 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Negative | Positive | Negative | Not done | 45.8 | Positive | null | Excisional biopsy | Yes | 18 | moderate_burden |
PATH-KEN-2018-00096 | Kenya | 2,018 | Regional | Stomach | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Negative | Negative | 45.6 | Negative | null | Excisional biopsy | Yes | 22 | moderate_burden |
PATH-TAN-2019-00097 | Tanzania | 2,019 | Regional | Cervix | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Not documented | Close | Negative | Positive | Negative | Not done | Positive | null | Excisional biopsy | No - inconclusive | 6 | moderate_burden |
PATH-KEN-2023-00098 | Kenya | 2,023 | District | Colorectal | 8070/3 | Squamous cell carcinoma | Undifferentiated | Present | Absent | Negative | Positive | Positive | Negative | 19.9 | Negative | null | Resection | No - inconclusive | 3 | moderate_burden |
PATH-KEN-2022-00099 | Kenya | 2,022 | District | Colorectal | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Close | Negative | Not done | Negative | Not done | Positive | null | Excisional biopsy | No - inconclusive | 8 | moderate_burden |
PATH-TAN-2023-00100 | Tanzania | 2,023 | National referral | Bladder | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Negative | 68.4 | Negative | null | Core needle biopsy | Yes | 10 | moderate_burden |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.